Respiratory Alkalosis 

  • Author: April Lambert-Drwiega, DO; Chief Editor: Zab Mosenifar, MD   more...
 
Updated: May 19, 2010
 

Background

Respiratory alkalosis is a clinical disturbance due to alveolar hyperventilation. Alveolar hyperventilation leads to a decreased partial pressure of arterial carbon dioxide (PaCO2), or partial pressure of carbon dioxide (PCO2). In turn, the decrease in PCO2 increases the ratio of bicarbonate concentration to PCO2 and increases the pH level. The decrease in PCO2 (hypocapnia) develops when a strong respiratory stimulus causes the lungs to remove more carbon dioxide than is produced metabolically in the tissues. Respiratory alkalosis can be acute or chronic. In acute respiratory alkalosis, the PCO2 level is below the lower limit of normal and the serum pH is alkalemic. In chronic respiratory alkalosis, the PCO2 level is below the lower limit of normal, but the pH level is normal or near normal.

Respiratory alkalosis is the most common acid-base abnormality observed in patients who are critically ill. It is associated with numerous illnesses and is a common finding in patients on mechanical ventilation. Many cardiac and pulmonary disorders can manifest respiratory alkalosis as an early or intermediate finding. When respiratory alkalosis is present, the cause may be minor; however, more serious disease processes should also be considered in the differential diagnosis.

Next

Pathophysiology

Breathing is the body’s way of providing adequate amounts of oxygen for metabolism and for removing carbon dioxide produced by the tissues. By sensing the body’s partial pressure of oxygen (PO2) and PCO2, the respiratory system adjusts pulmonary ventilation so that oxygen uptake and carbon dioxide elimination at the lungs is equal to that used and produced by the tissues. PO2 is not as closely regulated because adequate hemoglobin saturation can be achieved over a wide range of PO2 levels. Oxygen is dependent on pressure gradients whereas, carbon dioxide diffuses much easier through an aqueous environment, making carbon dioxide regulation more complex. The PCO2 must be maintained at a level that ensures hydrogen ion concentrations remain in the narrow limits required for optimal protein function.

Metabolism generates a large quantity of volatile acid (carbon dioxide) and nonvolatile acid. The metabolism of fats and carbohydrates leads to the formation of a large amount of carbon dioxide.[1] The carbon dioxide combines with water to form carbonic acid. The lungs excrete the volatile fraction through ventilation, and acid accumulation does not occur. Significant alterations in ventilation can affect the elimination of carbon dioxide and lead to a respiratory acid-base disorder.

PCO2 is normally maintained in the range of 37-43 mm Hg. Chemoreceptors in the brain (central chemoreceptors) and in the carotid bodies (peripheral chemoreceptors) sense hydrogen concentrations and influence ventilation to adjust the PCO2, PO2, and pH. Under this feedback regulator is how the PCO2 is maintained within its narrow normal range. When these receptors sense an increase in hydrogen ions, breathing is increased to “blow off” carbon dioxide and subsequently reduce the amount of hydrogen ions. Various disease processes may cause stimulation of ventilation with subsequent hyperventilation. If hyperventilation is persistent, it leads to hypocapnia.

Hyperventilation refers to an increase in the rate of alveolar ventilation that is disproportionate to the rate of metabolic carbon dioxide production, leading to an arterial PCO2 below the normal range. Two words often used synonymously with hyperventilation are tachypnea, an increase in respiratory frequency, and hyperpnea, an increase in the minute volume of ventilation. These should not be used to describe hyperventilation because they are distinct entities and neither results from nor means a change in PCO2. Hyperventilation is often associated with dyspnea, but not all patients who are hyperventilating complain of shortness of breath. Conversely, patients with dyspnea need not be hyperventilating.

Acute hypocapnia causes a reduction of serum levels of potassium and phosphate secondary to increased intracellular shifts of these ions. A reduction in free serum calcium also occurs. Calcium reduction is secondary to increased binding of calcium to serum albumin. Many of the symptoms present in persons with respiratory alkalosis are related to the hypocalcemia.[2] Hyponatremia and hypochloremia may also be present.

Acute hyperventilation with hypocapnia causes a small, early reduction in serum bicarbonate levels resulting from cellular uptake of bicarbonate. Acutely, plasma pH and bicarbonate concentration vary proportionately with the PCO2 along a range of 15-40 mm Hg. The relationship of PCO2 to arterial hydrogen and bicarbonate is 0.7 mmol/L per mm Hg and 0.2 mmol/L per mm Hg, respectively.[3] After 2-6 hours, respiratory alkalosis is renally compensated by a decrease in bicarbonate reabsorption. The kidneys respond more to the decreased PCO2 rather than the increased pH. Kidney compensation may take several days and requires normal kidney function and intravascular volume status.[3] The expected change in serum bicarbonate concentration can be estimated as follows:

  • Acute - Bicarbonate (HCO3-) falls 2 mEq/L for each decrease of 10 mm Hg in the PCO2; that is, ΔHCO3 = 0.2(ΔPCO2); maximum compensation: HCO3- = 12-20 mEq/L
  • Chronic - Bicarbonate (HCO3-) falls 5 mEq/L for each decrease of 10 mm Hg in the PCO2; that is, ΔHCO3 = 0.5(ΔPCO2); maximum compensation: HCO3- = 12-20 mEq/L

Note that a plasma bicarbonate concentration of less than 12 mmol/L is unusual in pure respiratory alkalosis alone and should prompt the consideration of a metabolic acidosis as well.[2]

The expected change in pH with respiratory alkalosis can be estimated with the following equations:

  • Acute respiratory alkalosis: Change in pH = 0.008 X (40 – PCO2)
  • Chronic respiratory alkalosis: Change in pH = 0.017 X (40 – PCO2)
Previous
Next

Epidemiology

Frequency

United States

The frequency of respiratory alkalosis varies depending on the etiology. The most common acid-base abnormality observed in critically ill patients is chronic respiratory alkalosis.[3]

Mortality/Morbidity

Morbidity and mortality of patients with respiratory alkalosis depend on the nature of the underlying cause of the respiratory alkalosis and associated conditions.

Previous
 
 
Contributor Information and Disclosures
Author

April Lambert-Drwiega, DO  Fellow, Department of Pulmonology and Critical Care Medicine, East Tennessee State University

April Lambert-Drwiega, DO is a member of the following medical societies: American College of Chest Physicians, American College of Physicians, American Medical Association, American Osteopathic Association, American Thoracic Society, Society of Critical Care Medicine, and Southern Medical Association

Disclosure: Nothing to disclose.

Coauthor(s)

Ryland P Byrd Jr, MD  Professor, Department of Internal Medicine, Division of Pulmonary Medicine and Critical Care Medicine, Program Director of Pulmonary Diseases and Critical Care Medicine Fellowship, James H Quillen College of Medicine, East Tennessee State University; Medical Director of Respiratory Therapy, James H Quillen Veterans Affairs Medical Center

Ryland P Byrd Jr, MD is a member of the following medical societies: American College of Chest Physicians and American Thoracic Society

Disclosure: Nothing to disclose.

Specialty Editor Board

Oleh Wasyl Hnatiuk, MD  Program Director, National Capital Consortium, Pulmonary and Critical Care, Walter Reed Army Medical Center; Associate Professor, Department of Medicine, Uniformed Services University of Health Sciences

Oleh Wasyl Hnatiuk, MD is a member of the following medical societies: American College of Chest Physicians, American College of Physicians, and American Thoracic Society

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD  Senior Pharmacy Editor, eMedicine

Disclosure: eMedicine Salary Employment

Gregg T Anders, DO  Medical Director, Great Plains Regional Medical Command , Brooke Army Medical Center; Clinical Associate Professor, Department of Internal Medicine, Division of Pulmonary Disease, University of Texas Health Science Center at San Antonio

Gregg T Anders, DO is a member of the following medical societies: American College of Chest Physicians, American College of Physicians, and American Thoracic Society

Disclosure: Nothing to disclose.

Timothy D Rice, MD  Associate Professor, Departments of Internal Medicine and Pediatrics and Adolescent Medicine, St Louis University School of Medicine

Timothy D Rice, MD is a member of the following medical societies: American Academy of Pediatrics and American College of Physicians

Disclosure: Nothing to disclose.

Chief Editor

Zab Mosenifar, MD  Director, Division of Pulmonary and Critical Care Medicine, Director, Women's Guild Pulmonary Disease Institute, Executive Vice Chair, Department of Medicine, Cedars Sinai Medical Center; Professor of Medicine, David Geffen School of Medicine at UCLA

Zab Mosenifar, MD is a member of the following medical societies: American College of Chest Physicians, American College of Physicians, American Federation for Medical Research, and American Thoracic Society

Disclosure: Nothing to disclose.

References
  1. Kazmaier S, Weyland A, Buhre W, et al. Effects of respiratory alkalosis and acidosis on myocardial blood flow and metabolism in patients with coronary artery disease. Anesthesiology. Oct 1998;89(4):831-7. [Medline].

  2. Effros RM, Wesson JA. Acid-Base Balance. In: Mason RJ, Broaddus VC, Murray JF, Nadel JA, eds. Murray and Nadel's Textbook of Respiratory Medicine. Vol 1. 4th ed. Philadelphia, PA: Elsevier Saunders; 2005:192-93.

  3. DuBose TD, Jr. Acidosis and Alkalosis. In: Kasper DL, Braunwald E, Fauci AS, Hauser Sl, Longo DL, Jameson JL,eds. Harrison's Principles of Internal Medicine. 16th. New York, NY: McGraw-Hill; 2005:270-1.

  4. Phillipson EA, Duffin J. Hypoventilation and Hyperventilation Syndromes. In: Mason RJ, Broaddus VC, Murray JF, Nadel JA, eds. Murray and Nadel's Textbook of Respiratory Medicine. Vol 2. 4th ed. Philadelphia, PA: Elsevier Saunders; 2005:2069-70, 2080-84.

  5. Goldman A. Clinical tetany by forced respiration. JAMA. 1922;78:1193-95.

  6. Haldane JS, Poulton EP. The effects of want of oxygen on respiration. J Physiol. 1908;37:390-407.

  7. Kirsch DB, Jozefowicz RF. Neurologic complications of respiratory disease. Neurol Clin. Feb 2002;20(1):247-64, viii. [Medline].

  8. Gardner WN. The pathophysiology of hyperventilation disorders. Chest. Feb 1996;109(2):516-34. [Medline].

Previous
Next
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.